- 2026-12-05
-
Targeting SIK2 initiates CD8+ T-cell immunity to enhance immunotherapy efficacy in ovarian cancer
07:35-07:42
Room 502
Mini Oral
Speaker

Fang Wang
Targeting SIK2 initiates CD8+ T-cell immunity to enhance immunotherapy efficacy in ovarian cancer
07:35-07:42
Room 502
Mini Oral
Speaker